The three-year agreement initiated October 2005 provides Dow AgroSciences with access to Sangamo's proprietary ZFP technology for the development of products in plants and plant cell cultures. During the initial three-year research term, Dow AgroSciences has the option to obtain a commercial license to sell products incorporating or derived from plant cells generated using Sangamo's ZFP technology, including agricultural crops, industrial products and plant-derived biopharmaceuticals.
Sangamo has also developed sequence-specific ZFNs for precision gene modification and targeted gene insertion. These technologies have the potential to play a major role in bringing new discoveries in genomics forward to the marketplace. The use of Sangamo's ZFP technology to enable the efficient and reproducible generation of combinations or stacks of multiple traits and the insertion of new traits could address increasing demand.
About Dow AgroSciences LLC
Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a
top-tier agricultural company that combines the power of science and
technology with the "Human Element" to constantly improve what is essential
to human progress. Dow AgroSciences provides innovative technologies for
crop protection, pest and vegetation management, seeds, traits, and
agricultural biotechnology to serve the world's growing population. Global
sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical
Company, are $3.8 billion. Learn more at http://www.dowagro.com.
|SOURCE Sangamo BioSciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved